Orion
54.6
EUR
+1.26 %
13,944 following
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Income statement
Valuation
Quarterly estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 977.5 | 1,051.0 | 1,078.1 | 1,041.1 | 1,340.6 | 1,189.6 | 1,542.4 | 1,630.8 | 1,892.8 | 1,749.6 | 1,889.6 |
growth-% | 7.5 % | 2.6 % | -3.4 % | 28.8 % | -11.3 % | 29.7 % | 5.7 % | 16.1 % | -7.6 % | 8.0 % | |
EBITDA | 293.9 | 308.9 | 336.5 | 289.0 | 486.6 | 326.4 | 629.6 | 464.6 | 669.9 | 517.3 | 545.1 |
EBIT (adj.) | 252.8 | 252.8 | 280.1 | 243.3 | 439.6 | 274.9 | 416.5 | 420.6 | 624.6 | 472.4 | 500.4 |
EBIT | 252.8 | 252.8 | 280.1 | 243.3 | 439.6 | 274.9 | 416.5 | 420.6 | 624.6 | 472.4 | 500.4 |
Profit before taxes | 248.4 | 250.8 | 278.3 | 242.3 | 440.3 | 271.9 | 413.0 | 416.6 | 621.2 | 471.6 | 500.9 |
Net income | 197.3 | 200.4 | 219.9 | 193.8 | 349.5 | 216.8 | 329.7 | 328.3 | 490.7 | 372.5 | 395.7 |
EPS (adj.) | 1.40 | 1.42 | 1.57 | 1.38 | 2.49 | 1.54 | 2.35 | 2.34 | 3.49 | 2.65 | 2.82 |
growth-% | 1.5 % | 9.9 % | -11.9 % | 80.3 % | -38.0 % | 52.1 % | -0.4 % | 49.5 % | -24.1 % | 6.2 % | |
Dividend | 1.50 | 1.50 | 1.50 | 1.50 | 1.60 | 1.62 | 1.65 | 1.70 | 1.75 | 1.80 | 1.85 |
Dividend ratio | 107.0 % | 105.3 % | 95.8 % | 108.7 % | 64.3 % | 105.0 % | 70.3 % | 72.7 % | 50.1 % | 67.9 % | 65.7 % |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 30.1 % | 29.4 % | 31.2 % | 27.8 % | 36.3 % | 27.4 % | 40.8 % | 28.5 % | 35.4 % | 29.6 % | 28.8 % |
EBIT-% (adj.) | 25.9 % | 24.1 % | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 27.0 % | 25.8 % | 33.0 % | 27.0 % | 26.5 % |
EBIT-% | 25.9 % | 24.1 % | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 27.0 % | 25.8 % | 33.0 % | 27.0 % | 26.5 % |
ROE | 25.8 % | 29.1 % | 26.8 % | 43.1 % | 24.1 % | 34.8 % | 31.2 % | 40.0 % | 26.3 % | 25.5 % | |
ROI | 29.5 % | 34.4 % | 29.5 % | 45.6 % | 24.9 % | 34.4 % | 31.3 % | 44.2 % | 32.0 % | 32.3 % |